000 | 01983 a2200577 4500 | ||
---|---|---|---|
005 | 20250516074015.0 | ||
264 | 0 | _c20130213 | |
008 | 201302s 0 0 eng d | ||
022 | _a2040-2058 | ||
024 | 7 |
_a10.3851/IMP1957 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTripodo, Claudio | |
245 | 0 | 0 |
_aLiver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients. _h[electronic resource] |
260 |
_bAntiviral therapy _c2012 |
||
300 |
_a111-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
650 | 0 | 4 |
_aBiomarkers, Pharmacological _xanalysis |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHepacivirus _xdrug effects |
650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
650 | 0 | 4 | _aInterferons |
650 | 0 | 4 |
_aInterleukins _xgenetics |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aRNA, Viral _xbiosynthesis |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
650 | 0 | 4 |
_aT-Lymphocytes, Helper-Inducer _xcytology |
650 | 0 | 4 |
_aViral Load _xdrug effects |
700 | 1 | _aPetta, Salvatore | |
700 | 1 | _aGuarnotta, Carla | |
700 | 1 | _aPipitone, Rosaria | |
700 | 1 | _aCabibi, Daniela | |
700 | 1 | _aColombo, Mario P | |
700 | 1 | _aCraxì, Antonio | |
773 | 0 |
_tAntiviral therapy _gvol. 17 _gno. 1 _gp. 111-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3851/IMP1957 _zAvailable from publisher's website |
999 |
_c21482292 _d21482292 |